Start Date
July 31, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
SIR-Spheres microspheres
SIR-Spheres yttrium-90 microspheres
FOLFOX6 cycles 1-3
Oxaliplatin 60 mg/m2, IV infusion, q 2 weeks Leucovorin 200 mg/m2, IV infusion, q 2 weeks 5-Fluorouracil 400 mg/m2, IV bolus, q 2 weeks 5-Fluorouracil 2.4 g/m2, IV infusion, q 2 weeks
FOLFOX6 cycles 4 onwards
Oxaliplatin 85 mg/m2 given, IV infusion, q 2 weeks Leucovorin 200 mg/m2 given, IV infusion, q 2 weeks 5-Fluorouracil 400 mg/m2, IV bolus, q 2 weeks 5-Fluorouracil 2.4 g/m2, IV infusion, q 2 weeks
Bevacizumab cycles 3 onwards
Bevacizumab 10 mg/m2, IV infusion, q 2 weeks commencing with the third cycle of chemotherapy
Carolinas Medical Center, Charlotte
William Beaumont Hospital, Royal Oak
Sacred Heart Medical Center, Spokane
Lead Sponsor
Sirtex Medical
INDUSTRY